![]()
|
Report Date : |
28.04.2008 |
IDENTIFICATION
DETAILS
|
Name : |
ORION LABORATORIES LIMITED |
|
|
|
|
Registered Office : |
153-154, Tejgaon Industrial Estate Dhaka-1280 |
|
|
|
|
Country : |
Bangladesh |
|
|
|
|
Financials (as on) : |
2007 |
|
|
|
|
Date of Incorporation : |
June, 1965 |
|
|
|
|
Com. Reg. No.: |
C-2376 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacturing and Selling of Whose Drugs and Medicines are Marketed mainly
in Dhaka Region |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Name: Orion Laboratories
Limited
Address: 153-154,
Tejgaon Industrial Estate
Dhaka-1280,
Country: Bangladesh
Tel No : 880-2-8829314, 8827797,
8829391, 8827798, 8827256, 8821357,
Fax No : 880-2-8826374
E-Mail: orion@bol-online.com
Established: June,
1965
Incorporation No: C-2376
Incorporation Date: 21st June, 1976
Legal Structure:
The subject is a private
limited company in corporate
With
the Registrar of Joint Stock Companies,
Dhaka,
Business Type:
Manufacturers and Sellers
Status: Satisfactory
Payments: No complaints have
been heard regarding payments
from local suppliers or banks.
Litigation: NIL
Head Office: 153-154, Tejgaon
Industrial Estate
Dhaka-1280,
Tel No : 880-2-8829314,
8827797, 8829391, 8827798, 8827256,
8821357
Fax No. : 880-2-8826374
E-Mail: orion@bol-online.com
Branch: NIL
Factory: 153-154, Tejgaon Industrial Estate
Dhaka-1280,
Name: Mr.Mohammad
Obaidul Karim
Designation: Chairman & Managing
Director
Name: Mrs.Arzuda
Karim
Designation: Director
Name: Mr.Ebadul
Karim
Designation: Director
Line of Business: Manufacturers
& Sellers
Range of
Products: 1 Tablets
1 Syrups
1 Capsules
1 Injections
1 Creams
1 Ointments
Terms of Sale: 1 Cash
1 Credit
Name: Agrani
Bank Limited
Branch: Wasa
Branch
Address: Kawranbazar
Dhaka
|
|
2007 |
2006 |
2005 |
|
Capital Investment |
Tk.42 million |
Tk.42 million |
Tk.42 million |
|
Turnover |
Tk.313 million |
Tk.311.6 million |
Tk.310.5 million |
|
Liability |
Tk.5 million |
Tk.7 million |
Tk.8 million |
|
Fixed Assets |
Tk.30 million |
Tk. 30 million |
Tk.30 million |
|
Authorized Capital |
: |
Tk.25 million |
|
Paid Up Capital |
: |
Tk.150,000.00 |
|
Each Share Value |
: |
Tk.100.00 |
|
CURRENCY |
UNIT |
BANGLADESHI TAKA |
|
GB Pound |
1 |
143.7238 |
|
U.S Dollar |
1 |
69.4023 |
|
European Euro |
1 |
101.3730 |
|
Japanese Yen |
1 |
0.6176 |
|
Australian Dollar |
1 |
63.2055 |
No. of Employees: 91
Executives------------------3
Junior Executives----------4
Chemists---------------------3
Field Staffs-----------------20
Supervisory Staffs- ------12
General Staffs-------------10
Technicians- ----------------6
Workers---------------------33
Office Area: 3,500
sq.ft (rented)
Factory Area: 18,000
(rented)
Warehouse Area: 5,200
sq.ft.(rented)
Raw
Materials From: 1 USA
1
Germany
1
France
1
Korea
1
UK
1
Taiwan
1
Pakistan
1
India
Name of
Brand: ORION
Subsidiaries: 1 Orion Infusion Limited
1 Orion Plus
Limited
Member: 1 Bangladesh Aushad Shilpa Samity,
Dhaka
Association, Dhaka
1 Dhaka Chamber of Commerce &
Industries,
Dhaka
The subject is a private limited company engaged in
manufacturing and selling of whose drugs and medicines are marketed mainly in
Dhaka region. The company are good and the prices are little lower than big
companies.
The directors are well conversant in their line of trade and
they are also experienced businessman. They are financially solvent and good at
his business commitments, it is reported.
The company is good for normal business engagements.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)